V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300003416 | 300002383 | 1.72 | 75.25 | Palliative (P) | 2015-03-14 | 2015-03-21 | Cisplatin +Fluorouracil (3 wk) | N | N | 300015550 | CISPLATIN + FLUOROURACIL |
| 300003417 | 300002384 | 1.73 | 74 | null | 2013-05-13 | 2013-05-23 | Cisplatin + Docetaxel +Fluorouracil | 01 | N | 300015557 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003418 | 300002384 | 1.6 | 67 | Adjuvant (A) | 2016-10-02 | 2016-10-02 | Capecitabine | N | N | 300015557 | CAPECITABINE |
| 300003419 | 300002385 | null | 87 | Neo-adjuvant (N) | 2013-08-29 | 2013-09-03 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 300015564 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003420 | 300002386 | 1.62 | 77 | Not known (9) | 2017-03-15 | 2017-03-19 | CISPLATIN + FLUOROURACIL | N | N | 300015568 | CISPLATIN + FLUOROURACIL |
| 300003421 | 300002387 | 1.64 | 79.8 | Neo-adjuvant (N) | 2017-12-19 | 2017-12-25 | Cisplatin +Fluorouracil (3 wk) | N | N | 300015571 | CISPLATIN + FLUOROURACIL |
| 300003422 | 300002387 | 1.73 | 124 | Neo-adjuvant (N) | 2016-05-27 | 2016-06-17 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300015571 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003423 | 300002388 | 1.52 | 55.1 | Curative (C) | null | 2013-07-16 | Cetuximab 7 day (Cycle 1) | Y | null | 300015578 | CETUXIMAB |
| 300003424 | 300005933 | null | 67 | null | 2013-03-10 | 2013-03-30 | Cetuximab 7 day (Cycle 1) | 02 | N | 300015582 | CETUXIMAB |
| 300003425 | 300002389 | 1.7 | 67.4 | Curative (C) | 2013-11-19 | 2013-11-20 | CETUXIMAB | 2 | N | 300015583 | CETUXIMAB |
| 300003426 | 300002390 | null | 104.1 | Adjuvant (A) | 2014-11-10 | 2014-11-10 | Capecitabine | 02 | N | 300015590 | CAPECITABINE |
| 300003427 | 300002391 | 1.65 | 65 | Neo-adjuvant (N) | 2017-03-30 | 2017-03-30 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 300015592 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003429 | 300002393 | 1.8 | 75.9 | Neo-adjuvant (N) | 2017-01-13 | 2017-01-15 | Cisplatin +Fluorouracil (3 wk) | Y | null | 300015599 | CISPLATIN + FLUOROURACIL |
| 300003430 | 300002394 | 1.53 | 68.1 | Adjuvant (A) | 2017-05-11 | 2017-05-30 | Capecitabine | 2 | N | 300015600 | CAPECITABINE |
| 300003431 | 300002395 | null | 84 | Not known (9) | 2016-08-12 | 2016-08-28 | CISPLATIN + FLUOROURACIL | N | N | 300015602 | CISPLATIN + FLUOROURACIL |
| 300003432 | 300002396 | 1.61 | 84.6 | Adjuvant (A) | 2015-08-31 | 2015-08-31 | Capecitabine | 02 | N | 300015609 | CAPECITABINE |
| 300003433 | 300002397 | 1.71 | 79.6 | Neo-adjuvant (N) | 2013-03-05 | 2013-03-23 | Cisplatin +Fluorouracil (3 wk) | N | N | 300015614 | CISPLATIN + FLUOROURACIL |
| 300003434 | 300002398 | 1.75 | 71 | null | 2016-03-07 | 2016-03-17 | CISPLATIN + FLUOROURACIL | N | N | 300015615 | CISPLATIN + FLUOROURACIL |
| 300003438 | 300002401 | 1.83 | 67.6 | Curative (C) | 2017-07-11 | 2017-07-19 | Capecitabine | N | N | 300015626 | CAPECITABINE |
| 300003439 | 300002402 | 1.59 | 68 | Neo-adjuvant (N) | 2013-08-21 | 2013-08-28 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300015630 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003440 | 300002403 | 1.83 | 58.5 | Curative (C) | 2013-04-20 | 2013-04-25 | CETUXIMAB + RT | N | Y | 300015632 | CETUXIMAB + RT |
| 300003441 | 300002404 | 1.49 | 73.5 | null | 2015-05-19 | 2015-07-18 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300015642 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003442 | 300002405 | 1.56 | 77 | Adjuvant (A) | null | 2014-08-04 | Capecitabine | N | N | 300015643 | CAPECITABINE |
| 300003443 | 300002405 | 1.62 | 77.3 | Curative (C) | null | 2014-06-07 | Trial Unspecified | N | N | 300015643 | TRIAL |
| 300003444 | 300007399 | 1.56 | 101.6 | Neo-adjuvant (N) | 2016-11-06 | 2016-12-03 | CETUXIMAB | N | Y | 300015655 | CETUXIMAB |
| 300003445 | 300002406 | null | 68.6 | Curative (C) | 2017-03-12 | 2017-03-27 | CETUXIMAB | null | Y | 300015658 | CETUXIMAB |
| 300003446 | 300002406 | 1.77 | 57.45 | Curative (C) | 2013-03-24 | 2013-04-10 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 300015658 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003449 | 300002408 | 1.44 | 97.4 | Curative (C) | 2016-07-13 | 2016-08-15 | CARBOPLATIN + PACLITAXEL | N | Y | 300015676 | CARBOPLATIN + PACLITAXEL |
| 300003450 | 300002409 | 1.73 | 104.3 | Adjuvant (A) | null | 2013-09-03 | Cisplatin +Fluorouracil (3 wk) | N | null | 300015680 | CISPLATIN + FLUOROURACIL |
| 300003451 | 300002409 | 1.57 | 87.4 | Adjuvant (A) | 2017-11-19 | 2017-12-14 | Capecitabine | N | null | 300015680 | CAPECITABINE |
| 300003452 | 300007400 | 1.52 | 64.9 | Adjuvant (A) | 2017-12-07 | 2018-01-02 | Cetuximab + Radiotherapy Load | N | Y | 300015690 | CETUXIMAB + RT |
| 300003453 | 300007400 | 1.67 | 93.5 | Neo-adjuvant (N) | 2013-02-06 | 2013-02-06 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 300015690 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003454 | 300002410 | 1.52 | 77.2 | Neo-adjuvant (N) | 2016-02-07 | 2016-02-09 | CISPLATIN + FLUOROURACIL | N | N | 300015697 | CISPLATIN + FLUOROURACIL |
| 300003455 | 300002411 | 1.67 | 84 | Neo-adjuvant (N) | 2015-11-24 | 2015-12-11 | CETUXIMAB + RT | 02 | Y | 300015699 | CETUXIMAB + RT |
| 300003456 | 300005939 | 1.77 | 75.4 | Curative (C) | 2014-12-11 | 2015-01-05 | Trial Unspecified | N | Y | 300015700 | TRIAL |
| 300003458 | 300002413 | 1.63 | 99.4 | Curative (C) | 2014-10-02 | 2014-11-12 | CETUXIMAB + RT | N | Y | 300015703 | CETUXIMAB + RT |
| 300003459 | 300002414 | 1.77 | 45.7 | Adjuvant (A) | null | 2013-07-24 | Capecitabine | N | N | 300015704 | CAPECITABINE |
| 300003460 | 300002415 | 1.67 | 80.55 | Curative (C) | 2013-04-21 | 2013-06-03 | Cetuximab 7 day (Cycle 1) | N | Y | 300015710 | CETUXIMAB |
| 300003461 | 300002416 | 1.8 | 83 | Neo-adjuvant (N) | 2013-03-12 | 2013-04-09 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 300015712 | CISPLATIN + FLUOROURACIL |
| 300003462 | 300002417 | null | null | Curative (C) | 2017-07-31 | 2017-08-18 | Cisplatin + Docetaxel +Fluorouracil | N | null | 300015714 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003463 | 300002417 | null | 84.4 | Curative (C) | 2014-03-25 | 2014-03-25 | CETUXIMAB | N | null | 300015714 | CETUXIMAB |
| 300003464 | 300002417 | null | null | null | 2013-03-24 | 2013-04-11 | CETUXIMAB + RT | 02 | N | 300015714 | CETUXIMAB + RT |
| 300003465 | 300002417 | 1.55 | 56.8 | null | null | 2014-06-01 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300015714 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003466 | 300002418 | 1.5 | 124 | Neo-adjuvant (N) | 2015-10-29 | 2015-10-29 | Cisplatin +Fluorouracil (2 wk) | 02 | null | 300015727 | CISPLATIN + FLUOROURACIL |
| 300003467 | 300002419 | 1.63 | 42 | Neo-adjuvant (N) | 2013-03-11 | 2013-03-27 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 300015731 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003468 | 300002419 | null | 99.4 | Neo-adjuvant (N) | 2018-01-17 | 2018-01-23 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 300015731 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003469 | 300002419 | null | 87.5 | Neo-adjuvant (N) | 2017-02-08 | 2017-02-15 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 300015731 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003470 | 300002419 | 1.71 | null | Adjuvant (A) | 2013-07-12 | 2013-07-12 | Cetuximab + Radiotherapy Load | N | null | 300015731 | CETUXIMAB + RT |
| 300003471 | 300002419 | 1.63 | 76.8 | Curative (C) | 2014-11-08 | 2014-11-23 | Cetuximab 7 day (Cycle 1) | 02 | null | 300015731 | CETUXIMAB |
| 300003472 | 300002420 | null | 66.4 | Neo-adjuvant (N) | null | 2013-03-31 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | null | 300015744 | CISPLATIN + DOCETAXEL + FLUOROURACIL |